A Phase 4 (Phase 2 in European Union), Open-Label, Multicenter Study Evaluating the Absorption and Systemic Pharmacokinetics and HPA Axis Suppression Potential of Topically Applied IDP-122 Lotion in Pediatric Subjects with Moderate to Severe Plaque Psoriasis
RecruitingCTIS2024-520058-39-00
Bausch Health Americas Inc., Bausch Health Americas Inc.Plaque Psoriasis
Start: 2020-12-28Target: 26Updated: 2025-01-28